Tevogen

TVGNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$377.414 M

$5.56 -2.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Tevogen (TVGN) has a market capitalization of $377.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$26.3M

Loss-making

Shares outstanding

6,511,540

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Tevogen lists more than one class of stock. Company figures above cover all classes combined.

TVGNW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#69Tectonic TherapeuticTECX$382.0M
#70Allogene TherapeuticsALLO$380.0M
#71TevogenTVGN$377.4M
#72C4 TherapeuticsCCCC$362.3M
#73Zura BioZURA$362.2M

What if Tevogen were worth as much as…

Open the what-if tool →

Gold $28.2T

$415,980.59

Per share 74,817× higher

Bitcoin $1.53T

$22,507.99

Per share 4,048× higher

Apple $5.02T

$73,891.62

Per share 13,290× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Tevogen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.